vs

Side-by-side financial comparison of Driven Brands Holdings Inc. (DRVN) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $535.7M, roughly 1.2× Driven Brands Holdings Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 11.4%, a 23.1% gap on every dollar of revenue. On growth, Driven Brands Holdings Inc. posted the faster year-over-year revenue change (6.6% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -4.0%).

Standard Brands was a packaged foods company, formed in 1929 by J. P. Morgan & Co. with the merger of:Fleischmann Company Royal Baking Powder Company E. W. Gillett Company of Canada (1929) - Toronto-based baking goods company founded by P. W. Gillett in 1852 Widlar Food Products Company Chase & Sanborn Coffee Company

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

DRVN vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.2× larger
RPRX
$622.0M
$535.7M
DRVN
Growing faster (revenue YoY)
DRVN
DRVN
+1.9% gap
DRVN
6.6%
4.8%
RPRX
Higher net margin
RPRX
RPRX
23.1% more per $
RPRX
34.4%
11.4%
DRVN
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
-4.0%
DRVN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DRVN
DRVN
RPRX
RPRX
Revenue
$535.7M
$622.0M
Net Profit
$60.9M
$214.2M
Gross Margin
Operating Margin
11.6%
62.4%
Net Margin
11.4%
34.4%
Revenue YoY
6.6%
4.8%
Net Profit YoY
507.2%
2.9%
EPS (diluted)
$0.37
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DRVN
DRVN
RPRX
RPRX
Q4 25
$622.0M
Q3 25
$535.7M
$609.3M
Q2 25
$551.0M
$578.7M
Q1 25
$516.2M
$568.2M
Q4 24
$836.5M
$593.6M
Q3 24
$502.3M
$564.7M
Q2 24
$518.8M
$537.3M
Q1 24
$482.0M
$568.0M
Net Profit
DRVN
DRVN
RPRX
RPRX
Q4 25
$214.2M
Q3 25
$60.9M
$288.2M
Q2 25
$47.6M
$30.2M
Q1 25
$5.5M
$238.3M
Q4 24
$-312.0M
$208.2M
Q3 24
$-14.9M
$544.0M
Q2 24
$30.2M
$102.0M
Q1 24
$4.3M
$4.8M
Operating Margin
DRVN
DRVN
RPRX
RPRX
Q4 25
62.4%
Q3 25
11.6%
70.1%
Q2 25
6.9%
36.3%
Q1 25
11.9%
94.0%
Q4 24
-41.6%
60.9%
Q3 24
9.9%
Q2 24
17.4%
50.2%
Q1 24
14.1%
-13.0%
Net Margin
DRVN
DRVN
RPRX
RPRX
Q4 25
34.4%
Q3 25
11.4%
47.3%
Q2 25
8.6%
5.2%
Q1 25
1.1%
41.9%
Q4 24
-37.3%
35.1%
Q3 24
-3.0%
96.3%
Q2 24
5.8%
19.0%
Q1 24
0.9%
0.8%
EPS (diluted)
DRVN
DRVN
RPRX
RPRX
Q4 25
$0.49
Q3 25
$0.37
$0.67
Q2 25
$0.29
$0.07
Q1 25
$0.04
$0.55
Q4 24
$-1.93
$0.46
Q3 24
$-0.09
$1.21
Q2 24
$0.18
$0.23
Q1 24
$0.02
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DRVN
DRVN
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$162.0M
$618.7M
Total DebtLower is stronger
$1.9B
$9.0B
Stockholders' EquityBook value
$793.5M
$9.7B
Total Assets
$4.2B
$19.6B
Debt / EquityLower = less leverage
2.44×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DRVN
DRVN
RPRX
RPRX
Q4 25
$618.7M
Q3 25
$162.0M
$938.9M
Q2 25
$166.1M
$631.9M
Q1 25
$152.0M
$1.1B
Q4 24
$149.6M
$929.0M
Q3 24
$204.2M
$950.1M
Q2 24
$148.8M
$1.8B
Q1 24
$165.5M
$843.0M
Total Debt
DRVN
DRVN
RPRX
RPRX
Q4 25
$9.0B
Q3 25
$1.9B
$8.9B
Q2 25
$2.1B
$8.0B
Q1 25
$2.6B
$7.6B
Q4 24
$2.7B
$7.6B
Q3 24
$2.7B
$7.6B
Q2 24
$2.9B
$7.6B
Q1 24
$2.9B
$6.1B
Stockholders' Equity
DRVN
DRVN
RPRX
RPRX
Q4 25
$9.7B
Q3 25
$793.5M
$9.6B
Q2 25
$743.4M
$9.5B
Q1 25
$643.2M
$9.8B
Q4 24
$607.3M
$10.3B
Q3 24
$962.8M
$10.3B
Q2 24
$942.8M
$9.8B
Q1 24
$906.2M
$9.9B
Total Assets
DRVN
DRVN
RPRX
RPRX
Q4 25
$19.6B
Q3 25
$4.2B
$19.3B
Q2 25
$4.3B
$18.3B
Q1 25
$5.3B
$17.6B
Q4 24
$5.3B
$18.2B
Q3 24
$5.8B
$18.0B
Q2 24
$5.8B
$17.7B
Q1 24
$5.9B
$16.1B
Debt / Equity
DRVN
DRVN
RPRX
RPRX
Q4 25
0.92×
Q3 25
2.44×
0.93×
Q2 25
2.82×
0.84×
Q1 25
4.07×
0.78×
Q4 24
4.37×
0.74×
Q3 24
2.84×
0.74×
Q2 24
3.03×
0.78×
Q1 24
3.21×
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DRVN
DRVN
RPRX
RPRX
Operating Cash FlowLast quarter
$79.2M
$827.1M
Free Cash FlowOCF − Capex
$39.5M
FCF MarginFCF / Revenue
7.4%
Capex IntensityCapex / Revenue
7.4%
Cash ConversionOCF / Net Profit
1.30×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$31.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DRVN
DRVN
RPRX
RPRX
Q4 25
$827.1M
Q3 25
$79.2M
$702.6M
Q2 25
$80.4M
$364.0M
Q1 25
$75.1M
$596.1M
Q4 24
$32.9M
$742.5M
Q3 24
$101.3M
$703.6M
Q2 24
$46.9M
$658.2M
Q1 24
$60.3M
$664.6M
Free Cash Flow
DRVN
DRVN
RPRX
RPRX
Q4 25
Q3 25
$39.5M
Q2 25
$9.0M
Q1 25
$18.9M
Q4 24
$-36.3M
Q3 24
$37.9M
Q2 24
$-19.5M
Q1 24
$-29.2M
FCF Margin
DRVN
DRVN
RPRX
RPRX
Q4 25
Q3 25
7.4%
Q2 25
1.6%
Q1 25
3.7%
Q4 24
-4.3%
Q3 24
7.5%
Q2 24
-3.8%
Q1 24
-6.1%
Capex Intensity
DRVN
DRVN
RPRX
RPRX
Q4 25
Q3 25
7.4%
Q2 25
13.0%
Q1 25
10.9%
Q4 24
8.3%
Q3 24
12.6%
Q2 24
12.8%
Q1 24
18.6%
Cash Conversion
DRVN
DRVN
RPRX
RPRX
Q4 25
3.86×
Q3 25
1.30×
2.44×
Q2 25
1.69×
12.06×
Q1 25
13.65×
2.50×
Q4 24
3.57×
Q3 24
1.29×
Q2 24
1.56×
6.45×
Q1 24
14.15×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DRVN
DRVN

Company Operated Store Sales$331.3M62%
Supply And Other$74.3M14%
Car Wash Segment$54.0M10%
Independently Operated Store Sales$51.4M10%
Advertising$27.9M5%
Employee Services Leasing Agreement$2.0M0%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons